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One peptidase can usually be distinguished from another biochemically by its action on proteins, pep-
tides and synthetic substrates. Since 1996, the MEROPS database (http://merops.sanger.ac.uk) has
accumulated a collection of cleavages in substrates that now amounts to 66,615 cleavages. The total
number of peptidases for which at least one cleavage is known is 1700 out of a total of 2457 different
peptidases. This paper describes how the cleavages are obtained from the scientiﬁc literature, how they
are annotated and how cleavages in peptides and proteins are cross-referenced to entries in the UniProt
protein sequence database. The speciﬁcity proﬁles of 556 peptidases are shown for which ten or more
substrate cleavages are known. However, it has been proposed that at least 40 cleavages in disparate
proteins are required for speciﬁcity analysis to be meaningful, and only 163 peptidases (6.6%) fulﬁl this
criterion. Also described are the various displays shown on the website to aid with the understanding of
peptidase speciﬁcity, which are derived from the substrate cleavage collection. These displays include a
logo, distribution matrix, and tables to summarize which amino acids or groups of amino acids are
acceptable (or not acceptable) in each substrate binding pocket. For each protein substrate, there is a
display to show how it is processed and degraded. Also described are tools on the website to help with
the assessment of the physiological relevance of cleavages in a substrate. These tools rely on the hy-
pothesis that a cleavage site that is conserved in orthologues is likely to be physiologically relevant, and
alignments of substrate protein sequences are made utilizing the UniRef50 database, in which in each
entry sequences are 50% or more identical. Conservation in this case means substitutions are permitted
only if the amino acid is known to occupy the same substrate binding pocket from at least one other
substrate cleaved by the same peptidase.
© 2015 The Author. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
In 2007, Barrett & Rawlings [1] proposed a list of criteria to
distinguish one peptidase from another. To be considered different,
any one of the following bioinformatics tests can be applied: the
two peptidases have similar biochemical characteristics but unre-
lated sequences; the two peptidases have related sequences but
different biochemical properties, different domain architectures or
the domains are in a different order; or the two peptidases have
greater than 50% sequence identity but are derived from nodes on a
phylogenetic tree that are not adjacent. In addition, the following
biochemical tests can be applied to distinguish two peptidases: the
peptidases act under signiﬁcantly different conditions; the pepti-
dases have different post-translational modiﬁcations; the.
B.V. This is an open access articlepeptidases are sensitive to different inhibitors; the peptidases act
on different substrates, or if they act on the same substrates then
the cleavage positions are different. It is the last two criteria with
which this paper is concerned.
A peptidase cleaves a substrate at the scissile bond, and sub-
strate residues either side of this bond are known as P1 and P10.
Residues towards the N-terminus of the substrate are on the non-
prime side, and are numbered P1, P2, P3, P4 and so on. Residues
towards the C-terminus are on the prime side and are numbered
P10, P20, P30, P40 and so on. A substrate binding pocket in the
peptidase that accommodates a substrate residue is named ac-
cording to the position the residue occupies in the substrate, except
that the “P” is replaced by an “S”. So the S1 binding pocket ac-
commodates the P1 residue, and the S40 binding pocket accom-
modates the P40 residue [2].
A collection of substrate cleavages has been assembled from the
scientiﬁc literature, annotated, cross-referenced where applicableunder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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MEROPS database. This collection was originally derived from the
CD-ROM version of the ﬁrst edition of the Handbook of Proteolytic
Enzymes (1998) [3], which also included a search facility to ﬁnd the
peptidases able to cleave a substrate at a particular position. By
knowing where in proteins, peptides or synthetic substrates
cleavages occur, it is possible to postulate the speciﬁcity of a
peptidase. By knowing which amino acids can occupy each sub-
strate binding position, it is also possible to infer whether or not
cleavage of a substrate at a particular position is likely to be
physiologically relevant from an alignment of protein sequences of
closely-related orthologues.
The MEROPS substrate cleavage collection has beenwidely used
to predict cleavages in substrates (for a review see Song et al. (2011)
[4]), and to predict what peptidase may be responsible for a known
cleavage, for example PROSPER [5]. The MEROPS collection has also
been used for the mapping of the human degradome and predic-
tion of “cleavage entropy” as an overall measure of peptidase
speciﬁcity [6], as well as in the development of the “protease web”,
the network of peptidase, substrate and inhibitor interactions [7].
This paper describes the MEROPS substrate cleavage collection
and the various displays present on the MEROPS website (http://
merops.sanger.ac.uk) which aid in understanding peptidase speci-
ﬁcity and the processing and degradation of a protein substrate. In
order to help determine whether or not a cleavage is physiologi-
cally relevant, a service is also described where a user can upload
substrate cleavages and receive by E-mail an analysis to show how
well conserved, in terms of peptidase binding, each cleavage is.
2. Materials and methods
2.1. Identiﬁcation of peptidases, homology searching, sequence
alignment and phylogenetic tree generation
A peptidase species was deﬁned according to the principles
established in Barrett & Rawlings (2007) [1]. The methods for ho-
mology searching, family building, and generation of protein
sequence alignments and phylogenetic trees are the same as those
described in Rawlings et al. (2014) [8]. In brief, the following
methods were used. Only the peptidase domain was used for
sequence searching and sequence alignment. For each family a type
example was chosen and for each peptidase species a holotype was
chosen. The type example and holotype were usually the sequence
of the best characterized peptidase in the family or protein species,
respectively. A BlastP search [9] of the NCBI non-redundant protein
sequence database was performed, using the family type example
sequence. Sequences retrieved with an E value of 0.01 or less were
considered homologues and included in the family. To ﬁnd more
distant homologues, a HMMER search [10] was performed using a
ClustalWalignment [11] of a selection of sequences from the family
that included an example from every phylum for which there was a
representative. Sequence alignments were built using MAFFT [12].
Phylogenetic trees were built from the family sequence alignment
using QuickTree [13].
2.2. Manual substrate cleavage curation
The scientiﬁc literature was searched manually for substrate
cleavage sites by peptidases. Data were acquired from over 7280
references. The following data were collected, transformed as
required and stored in a MySQL database. From the name of the
peptidase as given by the authors of the publication, a MEROPS
identiﬁer and, if possible, a MERNUM indicating the source organ-
ism, were assigned. From the name of the substrate and its source, a
UniProt accession was assigned where possible, and the namerecommended by UniProt was stored in the MySQL database, unless
the substrate was a peptide or was processed, in which case a pep-
tide name or a name to indicate that processing had occurred was
stored (for example, “Met-enkephalin” would be stored in prefer-
ence to “pro-opiomelanocortin” if the substrate was just the pep-
tide). Where more than one UniProt entry existed, the annotated
SwissProt accession, name and sequence where used in preference.
Where isoforms derived from alternative initiation and alternative
splicing were indicated in the UniProt database entry, the sequence
chosen as the representative sequence by UniProt was selected un-
less the original publication indicated that a particular isoform had
been used. Therewas no attempt tomap a cleavage to all isoforms on
the presumption that a change in sequence could lead to a change in
cleavage position. The cleavage position (the position of the P1 res-
idue in the substrate) was converted to the equivalent residue
number from the respective UniProt entry. Up to four residues either
side of the scissile bond (residues P4 to P40) were stored for each
cleavage. The residue range of the substrate used compared to the
sequence in the UniProt entry was also stored. This allowed for
annotation of peptide substrates derived from full-length proteins
and processing events, such as removal of signal and transit peptides
and precursor sequences. The CDC checksum for the UniProt entry
was also stored so that any changes to the sequence could be iden-
tiﬁed subsequently. Kinetic data (Km, Kcat, and/or Km/Kcat) were
stored where available. Annotations to indicate how the peptidase
and cleavage positionwere identiﬁed were also stored. The initials of
the curator and the date the cleavage was collected were also stored.
The referencewas stored in a ReferenceManager database (Thomson
Reuters) and the PubMed accession was obtained and stored where
possible. Any additional data that affected where cleavage occurred,
such as reactions conditions, where stored as a comment in the
MySQL database.
To ensure that curation was consistent, a Perl program was
written to aid cleavage data collection and storage. The user (either
the author or a summer student) was asked to enter his or her
initials; the UniProt accession of the protein substrate in question;
the cleavage position; the residue range of the substrate sequence
compared to the UniProt entry; the codes for how the cleavage was
identiﬁed and how the peptidase was identiﬁed; whether the
cleavage was physiological, non-physiological, pathological or
theoretical; whether the substrate was denatured; the reference
and its PubMed identiﬁer; and any comment.
Collection of cleavage data from the literature was also out-
sourced to Molecular Connections, Bangalore, India. Data were
returned to the author as an Excel spreadsheet and a pipeline
developed to extract data from the spreadsheet and import it into
the MySQL database. Existing substrate cleavage collections were
also imported into the MEROPS collection. These included data
from the CutDB database [14] and the CASBAH database of caspase
substrates [15].
A Perl program to check that the P4eP40 residues around the
cleavage position matched the sequence in the UniProt entry was
written as a quality control measure and to identify any subsequent
changes in the UniProt sequence.
Cleavage data were also stored for the cleavage of synthetic
substrates. These were manually entered into the database. For a
synthetic substrate it was not possible to map the sequence to a
UniProt database entry. The P4eP40 positions around the scissile
bondwere storedwhere possible (many synthetic substrates do not
have residues beyond P10 or P3), including a unique identiﬁer for
each N- or C-terminal blocking or reporter group occurring within
that range.
In certain cases, it was not possible to map a cleavage to a single
enzyme. This most frequently occurred when cleavage was per-
formed by an enzyme complex, such as the proteasome or
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performed by one or more enzymes, such as removal of the initi-
ating methionine by either of the eukaryotic methionyl amino-
peptidases, or where speciﬁcity overlapped, for example caspases-3
and -7. Instead of mapping the cleavage to an individual enzyme,
the cleavage was mapped to the peptidase family.
2.3. Automated collection of substrate cleavages from SwissProt
entries
Entries in the SwissProt section of UniProt are annotated for
removal of initiating methionine, signal and transit peptides, and
processing events to activate proteins or extract peptides and
proteins from polyproteins. These, if not already present in the
substrate cleavage collection, were automatically collected using a
Perl script. Removal of an initiating methionine was mapped to a
MEROPS identiﬁer either for methionyl aminopeptidase (for a
prokaryote) or theM24 family (for a eukaryote). Removal of a signal
peptidase was mapped to a MEROPS identiﬁer either for signal
peptidase or a signal peptidase complex (depending on whether
the source species was a prokaryote or a eukaryote). Where the
peptidase responsible for the cleavagewas not known, the cleavage
was not mapped to a speciﬁc peptidase or peptidase family.
Theoretical cleavages, for example the release of a predicted signal
peptide, were not collected.
2.4. Automated collection of substrate cleavages from proteomics
experiments
High-throughput identiﬁcation of proteins in a sample is known
as “proteomics”. In many proteomics experiments, proteins are
digested with a peptidase so that each protein can be identiﬁed
from the mass and charge (and sometimes sequence) of its pep-
tides. This requires a prior in silico digestion of all proteins in the
proteome, and the choice of the peptidase used for the digestion is
important: the peptidase must have a very simple speciﬁcity that is
easily predictable. For this reason, trypsin. which cleaves all lysyl
and arginyl bonds in a denatured protein, with the exception of
except Lys-Pro and Arg-Pro bonds, is frequently used. There are
many tools to perform theoretical cleavages, for example Peptide-
Mass (http://web.expasy.org/peptide_mass/, [16]) which predicts
cleaves by peptidases such as trypsin, chymotrypsin, peptidyl-Lys
metallopeptidase and glutamyl peptidase I as well as cleavages by
chemicals such as CnBr. The neXtProt database includes trypsin
digestions of all human proteins and indicates peptides unique to a
protein and whether a particular peptide is found in many human
proteins [17]. The PRIDE database [[18]; http://www.ebi.ac.uk/
pride/archive/] stores the results of proteomics experiments
where peptides are identiﬁed from a sample by mass spectroscopy.
There are a number of different techniques employed of which
PICS, TAILS, COFRADIC, Subtiligase, ChaFRADIC and N-terminomics
are the most well-known; these have been reviewed by Lai et al.
[19] and Schlage & auf dem Keller [20]. TAILS [21] and COFRADIC
[22] are techniques that have been employed to identify physio-
logical substrates, including naturally occurring N-termini.
Frequently, the peptides derived from a protein can provide evi-
dence of post-translational processing, such as removal of an
initiating methionine, signal peptide or transit peptide. A Perl
program was written to collect peptides and their corresponding
UniProt entries from the PRIDE database and check each to see if
the N-terminus matched the site of removal of a hypothetical signal
or transit peptide. Because aminopeptidases may further trim an N-
terminus once a transit peptidase has been removed, for example
aminopeptidase P3 removes an unstable amino terminal tyrosine
from mitochondrial proteins following removal of the ﬁrst transitpeptide by mitochondrial processing peptidase but before removal
of a second transit peptide by mitochondrial intermediate pepti-
dase [23], the cleavage was only added to the MEROPS collection if
the peptide identiﬁed and the predicted processing event corre-
sponded. Cleavages from digests performed with more unusual
peptidases, such as glutamyl endopeptidase for example, were also
collected to boost the number of substrates for these peptidases.
In the last decade or so, there have been a number of attempts to
determine peptidase speciﬁcity or discover physiological substrates
by use of proteomics. In a typical proteomics experiment, a sample,
often a human cell lysate, is divided into two portions. The ﬁrst
portion is digested only by trypsin (or a similar peptidase with a
known and predictable speciﬁcity), and the second with trypsin
and a peptidase of choice. The peptides generated are identiﬁed by
mass spectroscopy. The cleavages that occur only in the second
portion are the result of the peptidase of choice. If the second
portion is digested ﬁrst by trypsin and then by the peptidase of
choice, then a suite of peptides is prepared to investigate the
speciﬁcity of the peptidase of choice and the cleavages by this
peptidase are not physiologically relevant. Alternatively, if the
second portion is digested ﬁrst with the peptidase of choice and
then by trypsin, the digested proteins are likely to include physi-
ological substrates. However, some proteins may be digested
because the usual physiological barriers to digestion (compart-
mentalization, differences in pH, etc) have been removed in the
experiment, and some proteins may be “bystanders” which are
cleaved under physiological conditions but the cleavage is non-
functional [24]. The results from analyses by software such as
Mascot [25] or PeptideProphet [26] are exported to Excel spread-
sheets. These are often deposited as material supplementary to the
paper, but spreadsheets have also been kindly supplied by the au-
thors. In a given sample, there can be hundreds or even thousands
of peptide products, so manual curation is not possible. A Perl
program was written to extract the accessions or identiﬁers,
translate them into UniProt accessions, and then determine the
residue number for the P1 residue in each cleavage. All of the
cleavages from the seminal paper by Schilling& Overall (2008) [27]
were collected, including cleavages by trypsin, but for subsequent
papers, trypsin cleavages were not collected.
2.5. Reliability scores
A “reliability score” is calculated which is an average percentage
difference for all substrates of a peptidase over the range P4eP40.
All possible pairwise comparisons are made and the number of
differences summed for all comparisons. For substrates with non-
standard amino acids and blocking and reporter groups such as
those found in synthetic substrates, the unusual residues are
replaced with “X” before the comparisons are performed. The sum
of differences is divided by the number of comparisons times the
number of positions considered. For most endopeptidases, the
number of positions considered is eight, because at least of one of
each of the positions P4 to P40 will be ﬁlled. However, for amino-
peptidases, where P4 to P2 are empty, and carboxypeptidases,
where P20 to P40 are empty, only ﬁve positions are considered. For
dipeptidyl-peptidases and peptidyl-dipeptidases only six positions
are considered, and for dipeptidases only two. The number of po-
sitions considered is calculated and not assumed. A peptidase with
a reliability score of greater than 75 means that its substrates are
varied in sequence and the calculated preferences are likely to be
correct. A peptidase with a score in the range 50e74% had a pro-
portion of substrates with similar sequences and thus the calcu-
lated preferences were less reliable, and the calculated preferences
for a peptidase with a score of less than 50% should be treated with
caution.
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3.1. Number of peptidases
By using the criteria of Barrett & Rawlings (2007) [1], it was
possible to distinguish 2457 different peptidase species. A holotype
was established for each of these. In addition, there are a further
250 different peptidase activities in the literature for which either
no or too little sequence information exists to be able to map any of
them to a UniProt accession. The breakdown into different catalytic
types is shown in Table 1. More serine peptidases (554 or 20%) were
found than for any other catalytic type.
The holotypes and their sequence homologues, 502,782 se-
quences in total, were found to be distributed amongst 254 fam-
ilies. This total includes 3669 sequences that are classiﬁed as
asparagine lyases rather than peptidases, because proteolysis is
dependent upon cyclization of an asparagine residue to a succini-
mide which does not involve hydrolysis [28].
3.2. Numbers of substrates
The total number of cleavages found for all peptidases was
66,615. This number includes substrates cleaved in the same po-
sition by different peptidases. Most of these cleavages (59,276 or
89%) were in peptides or proteins that could be mapped to UniProt
identiﬁers: 5821 (or 9%) were in synthetic substrates. The majority
of these cleavages (36,229 or 54%) are non-physiological, but
20,264 (30%) are thought to be physiologically relevant, and a
further 1349 (2%) are pathological. The totals include self-cleaving
reactions, which in the case of asparagine lyases is all the cleav-
ages identiﬁed for this catalytic type.
The breakdown of substrate cleavages per catalytic type is
shown in Table 2. Most cleavages (30,711 or 46%) are for serine
peptidases, a number boosted by the large number of non-
physiological cleavages (21,301 or 32%).
Table 3 shows the number of peptidases in each catalytic type
for which at least one substrate cleavage is known. The total
number is 1700 or 63% of the total number of different peptidases.
Comparing the numbers with those in Table 1 shows that for each
catalytic type, a substrate cleavage is known for most peptidases.
Substrates may be known for any of the other 1007 peptidases, but
cleavages were either not found or were not accessible in the
literature, or the site of cleavage is unknown. On average a pepti-
dase has 39 substrate cleavages in the MEROPS collection. Table 4
shows the peptidases with 10 or more known cleavages: the
large number of non-physiological cleavages for the serine pepti-
dase trypsin, 12,303 of which are derived from the proteomics
paper of Schilling & Overall (2008) [27], where it is used for
preparation of samples prior to mass spectroscopy analysis, ex-
plains the preponderance of cleavages for serine peptidases. To be
able to study peptidase speciﬁcity and make predictions about
where in a protein cleavage might occur, at least 40 cleavages in
substrates are required (Robert Pike, personal communication). The
number of peptidases with 40 or more cleavages is 163 (or 6% of the
total number of peptidases). It is immediately apparent that exceptTable 1
Counts of different peptidases (peptidase species) by catalytic type.
Aspartic Glutamic Metallo Cysteine
Sequenced and characterized 170 7 633 615
Sequenced only 118 0 327 297
Sequence not known 8 0 86 19
Non-peptidase homologues 4 0 103 52
Pseudogenes 24 0 5 21
Total 324 7 1154 1004for a small number of peptidases, insufﬁcient numbers of cleavages
in substrates are known to be able to draw ﬁrm conclusions about
the speciﬁcity of most peptidases. The distribution of cleavages per
peptidase is shown in Fig. 1.
There are 36 peptidases with 100 or more known cleavages in
physiological substrates. The peptidases with most physiological
cleavages are general processing peptidases, such as the animal
signal peptidase complex (a complex containing two peptidases
with 1879 cleavages) and methionyl aminopeptidase 1 (964
cleavages). Almost all of these cleavages are derived from annota-
tions in the SwissProt section of the UniProt database, and include
theoretical cleavages conﬁrmed by proteomics experiments sub-
mitted to the PRIDE database. Other peptidases with many physi-
ological cleavages include peptidases involved in protein turnover
such as cathepsins E (1553 cleavages) and D (871) and granzyme M
(891) almost all of which are derived from proteomics studies
[29,30]. There are 27 peptidases with 200 or more known cleavages
in substrates thought not to be physiological. As mentioned above,
the use of trypsin to produce peptides for mass-spectroscopy in
proteomics experiments means that more cleavages (14,201) are
known for this peptidase rather than any other. Large numbers of
non-physiological cleavages are also known for peptidases regu-
larly used in manual protein sequencing such as pepsin A (350
cleavages), peptidyl-Lys metallopeptidase (2105), chymotrypsin A
(1012), glutamyl peptidase 1 (1273) and lysyl endopeptidase (802).
Other peptidases with many non-physiological substrates are again
the subjects of proteomic studies: matrix metallopeptidase-2 (2726
cleavages) [27]; human granzyme B (1136) [30,31]; glutamyl
peptidase I (1003) [27]; cathepsins L (965), S (694) and B (486) [32];
meprin beta (891) and alpha subunits [33]; and the RC1339 protein
from Rickettsia conorii (799) [34]. There are 57 peptidases with 20
or more cleavages in synthetic substrates and neurolysin (139
cleavages) and thimet oligopeptidase (116) have themost. There are
43 peptidases with cleavages in a hundred or more proteins,
including cleavages in peptides that can be mapped to protein se-
quences in the UniProt database. Once again, because of its use in
proteomics, more proteins are known that are susceptible to
trypsin (3188) than any other peptidase. The methods by which
cleavages were identiﬁed include mass spectroscopy (40,729
cleavages), N-terminal sequencing (8284), from knowing the
consensus cleavage site (1609), amino acid analysis (205) and site-
directed mutagenesis (178).
3.3. Substrate speciﬁcity
Table 4 shows the speciﬁcity of peptidases based on the occur-
rence of amino acids in the binding pockets P4eP40. The prefer-
ences for each peptidase are deﬁned in words so that the table
represents a classiﬁcation by speciﬁcity and homology. This also
allows classiﬁcation by amino acid type (acidic, basic, aliphatic,
aromatic, etc) which would not be possible if logos were shown.
The MEROPS identiﬁer for each peptidase is a link to the peptidase
summary page on theMEROPS websitewhere the speciﬁcity logo is
displayed. Caution should be exercised where these preferences are
derived from fewer than 40 substrates. The number of peptidasesSerine Threonine Mixed Asparagine lyases Unknown Total
942 46 5 23 16 2457
644 29 0 1 3 1419
87 1 0 0 49 250
145 26 0 0 0 330
17 3 0 0 0 70
1835 105 5 24 68 4526
Table 2
Counts of substrates per catalytic type.
Aspartic Glutamic Metallo Cysteine Serine Threonine Mixed Asparagine lyases Unknown Total
Physiological 2780 7 4113 7311 5877 33 2 60 81 20,264
Pathological 266 0 345 700 34 0 0 0 4 1349
Non-physiological 2893 70 8762 3112 21,301 84 1 3 3 36,229
Synthetic 364 32 1569 1179 2547 42 37 0 51 5821
Theoretical 176 0 545 106 638 0 0 300 0 1765
Unclassiﬁed 77 0 554 194 314 26 1 0 21 1187
Total 6556 109 15,888 12,602 30,711 185 41 363 160 66,615
Table 3
Counts of peptidases with known substrate cleavages by catalytic type.
Aspartic Glutamic Metallo Cysteine Serine Threonine Mixed Asparagine lyases Unknown Total
Sequenced and characterized 114 4 477 401 520 18 2 17 33 1586
Sequence not known 5 0 41 6 34 0 0 0 28 114
Total 119 4 518 407 554 18 2 17 61 1700
N.D. Rawlings / Biochimie 122 (2016) 5e30 9for which the cleavage data are considered reliable (highlighted in
green) is 319. The number for which the data are less reliable
(yellow highlighting) is 123, and the number for which the data
should be treated with caution (red highlighting) is 68. The vast
majority of peptidases with a low reliability score are those
showing apparent speciﬁcity in more than three binding pockets. It
should be noted, however, that the reliability score will be affected
by the number of binding pockets in which speciﬁcity is shown:
this is apparent for the deubiquitinating hydrolases where the
substrates positions P4eP1 are occupied in physiological substrates
by the highly conserved C-terminus of ubiquitin
(LeueArgeGlyeGly). Because proteins substrates are unlikely to be
homologous, a peptidase with many protein substrates will have a
large reliability score. For a peptidase with cleavages in predomi-
nantly synthetic substrates, the reliability scorewill be low, because
synthetic substrates tend to be similar with only the blocking and
reporter groups differing. The peptidases with the highest reli-
ability scores (96%) are asclepain A (C01.008); the snake venom
enzyme jerdohagin (M12.216) and bpr peptidase from Dichelo-
bacter nodosus (S08.022). In all three examples, protein cleavages
are from the insulin B-chain [35e37]. The peptidase for which the
reliability score is lowest (12%) is polyglycine endopeptidase
(U9G.075): most known cleavages are from glycine-rich regions in
endochitinases [38].
The table shows where one or two amino acids predominate in
any binding pocket, or where a deﬁned group of amino acids pre-
dominate. Also shown are one or two amino acids that are un-
known in any substrate binding pocket where no preference is
known to exist. Because some amino acids are rare or rarely
encountered around a cleavage site, for example cysteine and
tryptophan, these negative preferences are only shown when 200
or more cleavages are known for the peptidase. Where a binding
pocket does not exist, for example P4eP2 for an aminopeptidase or
P20eP40 for a carboxypeptidase, these are shown with a grey
background. Please note that for some exopeptidases the name
indicates a preference and not a strict speciﬁcity. For example,
bacterial-type alanyl aminopeptidase (M01.005) has also been
shown to act as an endopeptidase [39]. DmpA aminopeptidase
(P01.001) also acts as an endopeptidase, processing its own pre-
cursor [40]. For many aminopeptidases, only cleavages in synthetic
substrates are known and these frequently lack residues in posi-
tions P20 to P40. These apparent absences in binding pockets
S20eS40 are not shown in Table 4 because they would be
misleading.
The majority of peptidases for which speciﬁcity can be inferred(107 endopeptidases and 43 exopeptidases) show a preference in a
single substrate binding pocket. Most of these peptidases show a
preference in the S1 pocket, but there is a preference in each
binding pocket S4eS40 for at least one endopeptidase. There is an
overwhelming bias for basic residues in P1, which probably reﬂects
the large number of characterized peptidases in family S1. Exo-
peptidases, perhaps unsurprisingly, show preference only in
pockets P1 and P10. The TET aminopeptidase is the only exopepti-
dase to show a preference beyond the residues either side of the
cleavage site.
Several peptidases show a preference in more than one binding
pocket. There are 79 peptidases with a preference in two binding
pockets, 50 peptidases with a preference in three pockets and 29
peptidases with a preference in four pockets. The table also in-
cludes examples of peptidases with preferences in more binding
pockets, but as with the case for thimet oligopeptidase (see below)
these apparent preferences are more likely to reﬂect the design of
the substrates tested rather than true speciﬁcities.
Despite the large number of cleavages in substrates, the speci-
ﬁcity of some peptidases cannot be explained in terms of prefer-
ences in binding pockets. Table 4 shows the 53 peptidases with
more than forty substrate cleavages for which no preference is
shown. This list includes some well-known and well-characterized
peptidases such as cathepsin G, for which even a large proteomics
study was unable to show any preference except that lysine is not
acceptable in P4 [27].
Table 4 also shows that peptidases with similar speciﬁcities can
be unrelated to one another (members of different families or even
catalytic types), for example gingipain K and bacterial lysyl endo-
peptidase both have a preference for Lys in P1, yet the former is a
cysteine peptidase and the latter a serine peptidase. There are also
examples where speciﬁcity differs markedly from peptidases with
homologous sequences, with examples from family S1 being the
most well known in which chymotrypsin A has a preference for
aromatic residues in P1, trypsin 1 for basic residues, elastase-2 for
aliphatic residues and granzyme B for aspartic acid. It is more un-
usual for peptidases within a family to utilise different substrate
binding pockets, but an example is granzyme B which also shows a
preference for an aliphatic residue in P4. A family may include exo-
as well as endopeptidases, for example family S9 includes prolyl
oligopeptidase and dipeptidyl-peptidase IV, although both have a
preference for Pro in P1. These facts emphasize that peptidases
cannot be classiﬁed to the protein species by speciﬁcity or sequence
similarity alone, but that both speciﬁcity and homology should be
taken into consideration.
N.D. Rawlings / Biochimie 122 (2016) 5e3010There are many peptidases for which the number of physio-
logical substrates is limited. These include proteins that process
themselves to remove a propeptide or to expose a N-terminal
nucleophile and then cease to function as peptidases. Examples
include the amidophosphoribosyltransferase precursor (C44.001)
[41] and the penicillin V acylase precursor (C59.001) [42], for both
of which the only known cleavage is to expose a new N-terminal
nucleophilic cysteine. Human peptidases such as renin (A01.007)
have few natural substrates but the number of cleavages is boosted
by synthetic substrates and peptides.
3.4. Displays on the MEROPS website
A variety of displays have been implemented on the MEROPS
website to aid understanding of peptidase speciﬁcity. The displays
include the following.Table 4
Peptidases with 10 or more known cleavages and peptidase speciﬁcity derived from subst
substrate cleavages are shown. Peptidases are arranged by speciﬁcity (number of binding
acid in alphabetical order) and then by MEROPS identiﬁer. For each peptidase, the MERO
and preferences for binding pockets P4 to P40 are shown. The brighter the shade of gre
(50e59% of substrates) to brightest green (90% or greater of substrates). Up to two amino a
is for any of a group of amino acids, or the preference for the group is greater than that for
(aromatic: Phe, Trp, Tyr),þ (acidic: Asp, Glu), (basic: Arg, His, Lys),S (small: Ala, Cys, Gly
group of amino acids exists, and where there are 200 or more cleavages, up to two amino
background. For exopeptidaseswhich act at N- and C-termini of proteins, no residuemay b
grey. Binding pockets shaded black or grey are ignored for the ordering of items in the ta
differences between substrates for the same enzyme, dividing the total differences by
multiplying by 100. Reliability scores of 75% or greater difference are highlighted in green;In each peptidase summary, where ten or more substrate
cleavages are known, a logo (generated by the Weblogo software,
http://weblogo.berkeley.edu/) and a speciﬁcity matrix are shown.
Fig. 2 shows the logo and speciﬁcity matrix for thimet oligopepti-
dase. In the logo, amino acid residues are shown as single-letter
abbreviations, and the greater the height of the letters the greater
the preference for the amino acid in that binding pocket [43]. The
binding pockets S4eS40 are numbered along the X axis as 1e8. In
the speciﬁcity matrix, amino acids are shown in three-letter nota-
tion, and the number of times each occurs within the range P4eP40
for a substrate is shown. The occurrence of each amino acid in each
binding pocket is calculated as a percentage of total cleavages, and a
different shade of green is used for each tenth percentile. The
brighter green the background highlighting, the greater the pref-
erence for that amino acid in the corresponding substrate binding
pocket. If an amino acid has not been observed in any bindingrate cleavages in theMEROPS collection. For each peptidase with ten or more known
pockets, then preference in each binding pocket in the order P4 to P40 , then by amino
PS identiﬁer, the recommended peptidase name, the number of substrate cleavages,
en, the greater the preference; ﬁve shades are shown ranging from darkest green
cids are shown in a binding pocket where a preference occurs. Where the preference
a single or amino acid, the following symbols are shown: l (aliphatic: Ile, Leu, Val), @
, Ser) andU (other: Asn, Gln, Met, Pro, Thr). Where no preference for an amino acid or
acids that are not acceptable in a binding pocket are shown as white text on a black
e possible in some binding pockets and in these cases the binding pockets are shaded
ble. The “Reliability score” is the percentage difference calculated by counting all the
the number of comparisons times the number of residues P4eP40 considered, and
scores 50% or greater in yellow, and scores of less than 50% in red. See text for details.
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Obviously, with some amino acids that occur less frequently (Cys
and Trp, for example), the number of cleavages should be taken into
consideration before any conclusions are drawn about negative
preferences by the peptidase.
The example in Fig. 2 is based on 125 cleavages. However, 80 of
these cleavages are derived from one reference [44] in which the
substrates based on Abz-GFSPFRQ-EDDnpwere synthesized to help
distinguish thimet oligopeptidase from its close relative neurolysin.
It is immediately obvious that the preferences shown in binding
pockets S4eS30 (Gly, Phe, Ser, Pro, Phe, Arg, Gln) reﬂect the residues
that were kept constant during the residue-scanning experiments.
This example serves as a cautionary note to show that apparentpreferences may reﬂect the methodology employed rather than
represent the true speciﬁcity of the peptidase.
For each peptidasewhere substrate cleavages are known there is
a page dedicated to listing the substrates and the known cleavage
positions. Fig. 3 shows sections of the table of substrates for thimet
oligopeptidase. For each cleavage, the substrate name is given, the
UniProt accession if the substrate is from a naturally occurring
protein, the residue range of the substrate with respect to the
Uniprot entry, the cleavage site, the nature of the substrate
(“cleavage type”), the evidence for the cleavage position (if known),
a reference and a cross-reference to the CutDB database [14].
There are also displays for protein substrates. One important
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Fig. 1. Cleavages per peptidase. The bar chart shows the number of known substrate
cleavages per peptidase on the Y axis and the count of peptidases with this number of
cleavages on the X axis.
N.D. Rawlings / Biochimie 122 (2016) 5e3024physiologically relevant is whether the cleavage site is conserved in
close homologues. A cleavage site that is not conserved is unlikely
to be physiologically relevant, although it may be pathologically
relevant in the species inwhich it occurs. Conservation should be in
terms of which residues are accepted in the binding pockets of the
peptidase and not just sequence conservation in the substrate
orthologues. This is only possible if a large number of substrate
cleavages are known for the peptidase in question. Fig. 4 shows part
of the alignment for orthologues of the Ebola virus envelope
glycoprotein. The known cleavage is from the Zaire strain (UniProt
P87671) and cleavage is by ADAM17 (MEROPS ID M12.217) at res-
idue 637; the cleavage results in shedding of the ectodomainwhich
circulates in the blood of the patient and may interfere with anti-
bodies thus helping to prolong infection [45]. The alignment isFig. 2. Example of a speciﬁcity logo and distribution matrix. The speciﬁcity logo and distr
the greater the preference in substrate binding pockets S4 to S40 (numbered as 1 to 8 on the X
range P4 to P40 in substrates is shown. The brighter the green highlighting, the greater the pr
occupy a speciﬁc binding pocket is shown as white text on a black background. Amino acidynamically generated from the sequences clustered in the Uni-
Ref50 database entry that contains this sequence. The UniRef50
database entry contains sequences that share 50% or more
sequence identity [46]. Alignments are generated using MUSCLE
[47]. The sequence containing the known cleavage site is high-
lighted in green. Residues in the range P4eP40 are highlighted in
pink if they are identical to that from the Zaire strain; substituted
residues are highlighted in orange if the amino acid from another
ADAM17 substrate is known to occupy the same binding pocket;
and substituted residues are shown as white on black if the amino
acid is not known to occupy the same binding pocket from any
ADAM17 substrate (“unacceptable replacements”).
In this example, in one sequence the residues around the
cleavage site have not been determined and are replaced by Xs, and
in sequences from a number of strains of the virus the P10 residue is
replaced by His and the P20 residue by Asp or Asn, which have not
been observed in any of the 59 other substrates for ADAM17. The
possible conclusions are: 1) ADAM17 is not the physiological
peptidase that performs this cleavage, 2) some Ebola virus envelope
glycoproteins are processed by a different peptidase, 3) the speci-
ﬁcity of ADAM17 has not been fully explored and His is permissible
in P10 and Asp or Asn in P20, or 4) it doesn't matter if the cleavage is
inefﬁcient in some cases provided some processing occurs.3.5. A service to test conservation of cleavage sites
The production of this cleavage collection has allowed the
installation of a service on the MEROPS website to help researchers
assess whether or not a particular cleavage is physiologically rele-
vant. Following on from the display described above, the philoso-
phy behind this service is that a cleavage site in a protein substrate
is most likely to be physiologically relevant if it is conserved. The
user can submit a list of cleavage sites in a ﬁle the structure ofibution matrix are shown for thimet oligopeptidase. In the logo, the taller the character
axis). In the speciﬁcity matrix the number of times an amino acid occurs in the residue
eference for an amino acid in that position. An amino acid that has not been observed to
ds are ordered so that amino acids with similar properties are grouped together.
Fig. 3. Example of a substrate page. Part of the substrates page for thimet oligopeptidase is shown. For each substrate the following are shown: name; a cross-reference and link to
the entry in the UniProt database where appropriate; the residue range of the substrate as used in the experiment with reference to the numbering in the UniProt entry; a
description of the cleavage where the scissile bond is represented by the symbol ‘þ’; whether the cleavage is physiological, non-physiological, pathological or in a synthetic
substrate; the evidence by which the cleavage site was determined; the residues occupying residues P4 to P40 in the substrate; the source reference; and a cross-reference and link
to the CutDB database [14]. By default substrates are listed alphabetically, but the order can be changed by clicking the column heading. It is possible to ﬁlter the results for
physiological, nonphysiological, pathological or cleavages in synthetic substrates by clicking on the appropriate letter in the table legend.
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Table 5
An example of a ﬁle for submission to the Analyse Substrates service.










































N.D. Rawlings / Biochimie 122 (2016) 5e30 27which is shown in Table 5. This should be a text ﬁle created with
software such as Notepad and not a document ﬁle created with a
word processing package such as Word. The data required per line
are: MEROPS identiﬁer of the peptidase performing the cleavage,
the UniProt accession for the substrate protein, and the position of
the residue occupying the S1 binding pocket (the residue after
which cleavage occurs) taken from the full coding sequence in the
UniProt entry. For each line, an alignment is generated from the
sequences in the UniRef50 entry containing the UniProt accession
of the substrate protein, and the number of unacceptable re-
placements is counted. A ﬁle is generated and is E-mailed to the
user. An example of a results ﬁle is shown in Table 6. For each line in
the table the following are included: the MEROPS identiﬁer of the
peptidase; the total number of cleavages known for that peptidase;
the UniProt accession of the substrate protein; the number of ho-
mologues aligned from the UniRef50 entry; the cleavage position;
the number of unacceptable replacements at P4, P3, P2, P1, P10, P20,
P30 and P40; and a URL to display the substrate alignment at the
MEROPS website (to conserve space, the URL column is not shown
in Table 6). The number of known substrate cleavages for the
peptidase is returned because this will help the user assess the
reliability of the analysis: the more cleavages the more reliable the
analysis. Similarly, the number of sequences in the alignment will
help the user assess the results: if the alignment contains many
sequences and the cleavage site is well conserved, then the likeli-
hood that the cleavage site is physiologically relevant is greater. If
on the other hand the cleavage site is not conserved, and there are
many sequences in the alignment, then it is much more likely that
the cleavage is not physiologically relevant.
If the number of unacceptable replacements in positions P4eP40
is zero, then the cleavage site is extremely well conserved and is
likely to represent a physiological cleavage by the peptidase con-
cerned. If the number of unacceptable replacements is small, then
the cleavage may still be physiological. The most common expla-
nation is that the UniRef50 entry on which the alignment is based
contains two or more very closely related paralogues, one of which
is a physiological substrate, but the other is not. A second possibility
is that the sequences in the UniRef50 entry represent species var-
iants of only one protein, but one or more is derived from genomic
sequencing and is either a fragment (perhaps because the initiating
methionine has been misidentiﬁed or an anomalous frame-shift
has been introduced which truncates the C-terminus), or is
missing the exonwhich codes for all or part of the cleavage site. The
user is advised to consult the alignment via the URL provided to
check. If the number of unaccepted replacements is high, then the
cleavage site is not conserved and the cleavage is unlikely to be
physiologically signiﬁcant. However, the user should check the
number of cleavages for the peptidase: if this is less than 40, then it
is possible that there is not enough variation amongst the known
cleavage site sequences to account for the substitutions that have
occurred. It is possible that many homologues in the alignment
have the same replacement which has not been observed in any
substrate for the peptidase, simply because not enough substrates
have been found.
The user should also be aware that if there is a high number of
unacceptable replacements in one position, this requires further
investigation, because substitution to a rare amino acid may have
taken place. For a peptidase with no preference in a binding pocket,
for example S30, almost any amino acid can occupy the P30 position.Fig. 4. Example of a substrate alignment. Part of the alignment for orthologues of the Ebo
from the Zaire strain (UniProt P87671) by ADAM17 (MEROPS ID M12.217) at residue 637 h
identical to that from the Zaire strain; substituted residues are highlighted in orange if the am
and substituted residues are shown as white on black if the amino acid is not known to ocIn the alignment of substrate homologues, the count of unaccept-
able replacements is therefore likely to be small. However, if no
substrate is known with cysteine in P30, for example, yet many
homologues of a known substrate have a replacement cysteine in
P30, then the unacceptable replacement count will be high. In such
an example, it is simply not known if cysteine is acceptable in P30,
so it is impossible to say if the cleavage is physiological or not. The
user should check the alignment for such a replacement.
I would like to reiterate that a cleavage site that is not conserved
could still be important pathologically. The user is advised to check
the preferences for the peptidase on the peptidase summary page
in MEROPS to see if, for example, a large number of mismatches in
P40 is relevant.
This service is known as “Analyse Substrates” and is accessed
from the main menu on the website. It is particularly useful for
proteomics studies in which hundreds of potential physiological
substrates are found. The limitations on the service are that the
maximum number of cleavages per ﬁle uploaded is 5000 and the
maximum ﬁle size is 10 Mbytes.la virus envelope glycoprotein is shown, with the known cleavage of the glycoprotein
ighlighted in green. Residues in the range P4eP40 are highlighted in pink if they are
ino acid from another ADAM17 substrate is known to occupy the same binding pocket;
cupy the same binding pocket from any ADAM17 substrate.
Table 6

























A01.004 24 P05067 352 671 10 7 25 5 0 0 0 1
A01.009 897 P05067 352 705 0 0 0 0 0 0 1 0
A01.009 897 P05067 352 713 0 0 1 1 6 5 5 5
A01.009 897 P05067 352 714 0 1 1 6 5 5 5 5
A01.009 897 P05067 352 719 0 0 0 0 0 1 1 1
A01.009 897 P05067 352 720 0 0 0 0 1 1 1 3
A01.041 33 P05067 352 690 0 2 2 1 1 3 1 10
A01.041 33 P05067 352 691 2 2 1 1 1 1 1 1
A22.001 16 P05067 352 711 1 0 0 1 1 2 6 6
A22.001 16 P05067 352 713 4 1 1 2 6 5 5 5
A22.001 16 P05067 352 714 0 1 1 6 5 5 5 8
C01.060 632 P05067 352 704 0 0 0 0 0 0 0 1
C01.060 632 P05067 352 708 0 0 0 1 0 0 0 1
C01.060 632 P05067 352 711 1 0 0 0 1 1 5 5
C01.084 19 P05067 352 685 1 0 30 1 6 1 3 3
C01.084 19 P05067 352 685 1 0 30 1 6 1 3 3
C01.084 19 P05067 352 685 1 0 30 1 6 1 3 3
C01.084 19 P05067 352 689 0 1 3 2 2 6 4 2
C01.084 19 P05067 352 690 1 3 3 1 5 4 4 8
C01.084 19 P05067 352 690 1 3 3 1 5 4 4 8
C14.003 651 P05067 352 739 1 1 4 4 3 3 3 3
C14.005 201 P05067 352 672 7 5 4 16 0 0 0 0
C14.005 201 P05067 352 739 1 1 4 4 3 3 3 3
M02.001 5 P05067 352 711 1 1 4 1 1 2 173 173
M10.003 3417 P05067 352 687 2 0 0 0 0 1 1 1
M10.003 3417 P05067 352 705 0 0 0 0 0 0 1 0
M10.003 3417 P05067 352 706 0 0 0 0 0 1 0 0
M10.004 369 P05067 352 687 2 0 0 0 0 1 1 1
M10.004 369 P05067 352 691 0 1 1 1 1 1 1 1
M10.004 369 P05067 352 694 0 0 0 0 0 0 0 0
M10.004 369 P05067 352 701 0 0 0 0 0 0 0 0
M10.004 369 P05067 352 704 0 0 0 0 0 0 0 1
M10.004 369 P05067 352 705 0 0 0 0 0 0 1 0
M10.014 132 P05067 352 579 0 0 0 0 0 0 0 0
M10.014 132 P05067 352 687 11 0 0 0 0 1 1 1
M10.016 20 P05067 352 463 0 0 0 0 0 0 0 9
M10.016 20 P05067 352 579 7 0 18 0 2 4 0 1
M10.016 20 P05067 352 622 13 6 19 2 1 6 11 6
M10.016 20 P05067 352 685 0 0 11 1 5 0 0 2
M10.017 27 P05067 352 685 0 0 11 1 5 0 0 2
M10.017 27 P05067 352 687 11 1 0 0 0 3 1 1
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Cleavages in substrates (proteins, peptides and synthetic sub-
strates) by proteolytic enzymes have been collected from the
literature. In total, 66,615 cleavages have been annotated for 1700
different peptidases (69% of the 2457 different peptidases so far
identiﬁed). The number of cleavages per peptidase varies greatly,
from zero to 13,770 for trypsin 1. Peptidases with the most known
cleavages are derived from proteomics experiments.
Users should be aware of the biases that may exist in the sub-
strate cleavage data for a peptidase. If the data are predominantly
derived from amino acid scanning experiments inwhich all but one
amino acid is changed in a variety of synthetic peptides, then the
apparent speciﬁcity will be affected by the amino acids that are
kept constant. Similarly, if the cleavages are in synthetic substrates,
then the amino acid variety may be limited with changes only to
blocking and reporter groups. To address this problem, a “reliability
score” has been introduced, which is the average percentage dif-
ference in the residues P4eP40 for all substrates for a peptidase. A
high reliability score will indicate a higher variety in residues
occupying substrate binding sites. However, this score is affected
when several of the substrate binding pockets that confer
speciﬁcity.
By analysing the residues that occupy the P4eP40 substrate
binding sites, it has been possible to categorize the speciﬁcity ofsome peptidases. A logo and speciﬁcity matrix is shown on the
MEROPS website for each of the 556 peptidases (22.7%) with ten or
more substrate cleavages. Of these, 107 endopeptidases and 43
exopeptidases show a preference in one substrate binding pocket,
79 peptidases show a preference in two binding pockets, 50 show a
preference at three binding pockets, 29 show a preference at four
binding pockets and 53 show no positive preference in any sub-
strate binding site. However, it has been proposed that at least 40
cleavages in disparate proteins are required for speciﬁcity analysis
to bemeaningful, and only 163 peptidases (6.6%) fulﬁl this criterion.
Proteomics experiments inwhich cleavage sites are identiﬁed by
mass spectroscopy provides the bulk of the substrate cleavage data.
However, a common problem is that in order to extract the proteins
from the sample, the natural, physical boundaries that separate
peptidase from substrate may have been removed, and a large
number of substrate cleavages are generated. While this is not a
problem if no claims are made about the physiological relevance of
the data and the suite of peptides are generated just to examine
peptidase speciﬁcity, there are issues when it is claimed that the
experiment will reveal physiological substrates. The biggest
concern is that not all substrates will be physiological, but dis-
tinguishing these from artefactual and bystander substrates is
difﬁcult. A bioinformatics approach that has been adopted here is to
consider whether the cleavage is conserved in orthologues of the
substrate protein. For each cleavage site, the UniProt accession of
N.D. Rawlings / Biochimie 122 (2016) 5e30 29the substrate protein is determined, as well as the UniRef50 cluster
of sequences to which it belongs. All protein sequences from the
UniRef50 cluster are then aligned, and the residues P4eP40 for each
cleavage site are examined for conservation. The number of re-
placements that are not found to occupy the same binding pocket
in any of the substrates for the peptidase is counted. If this number
is high, then the likelihood that the substrate is physiologically
relevant is low. A server has been set up at the MEROPS website
whereby the results from a proteomics experiment to study
peptidase speciﬁcity can be uploaded, and the conservation around
each cleavage site examined. Results are returned by E-mail.
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